To evaluate the in-vivo safety and efficacy of Hair care formulation in terms of reduction in hair fall and reduction in dandruff on healthy human subjects. - Nil

Patanjali Ayurved Limited0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年8月19日

试验速览

暂无简介。

•1. For female: Being pregnant or breastfeeding or having stopped to breastfeed in the past three
•2. Having refused to give his/her assent by not signing the consent form
•3. Taking part in another study liable to interfere with this study4. Being insulin-dependent diabetic or non-insulin-dependent diabetic with a recent therapy (less than 6 months)
•5. Having a progressive asthma (either under treatment or last fit in the last 2 years)
•6. Being epileptic.
•7. Having non stabilized thyroid problems (requirement of a stabilized treatment for at least 6 months)
•8. Having cutaneous hypersensitivity
•9. Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products.
•10. Following a chronic medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, anti-histamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol)
•11. Having undergone a surgery requiring a general anaesthetic of more than one hour in the past 6 months.

发起方

Patanjali Ayurved Limited